Given this risk, we thought we'd take a look at whether Vor Biopharma (NASDAQ ... are increasing investment in future growth, but not too quickly. That's not necessarily a bad thing, but investors ...

Vor Biopharma isn't enormous, but it's not particularly small either. It has a market capitalization of US$878m, which means it would generally expect to see some institutions on the share registry.